Reuters

LONDON (Reuters) - Patients with type 2 diabetes taking GLP-1 treatments, which include Ozempic, have a lower chance of developing 10 types of obesity-related cancers than those taking insulin and other diabetes drugs, according to a study published on Friday.

Diabetes patients on GLP-1s instead of insulin have lower cancer risk, study shows

New research suggests that the diabetes drug and popular weight loss treatment semaglutide, sold as Ozempic and Wegovy, is linked with a significantly lower risk of dementia — possibly adding to the drug's large list of surprising and unexpected benefits. The study, published in the journal eClinicalMedicine, involved analyzing...

Ozempic Linked to Significantly Reduced Dementia Risk

USA TODAY

The first large, head-to-head comparison between next-generation weight loss drugs finds a clear advantage to one.

Ozempic v. Mounjaro? There's a clear winner for weight loss, study finds.

Trials have already shown that Novo Nordisk’s semaglutide can cut the risk of cardiovascular events and kidney disease. Now a study from the University of Oxford indicates that the company’s semaglutide type 2 diabetes drug Ozempic can reduce the risk of dementia compared with another popular diabetes medicine.

Novo Nordisk's Ozempic cuts dementia risk compared with Merck's Januvia: Oxford study

Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. That's according to a new University of Oxford analysis published last week, which found that Ozempic could lower the risk of dementia and a range of other mental problems compared with other existing treatments for patients with diabetes. What's more, researchers found that Ozempic cut nicotine dependence in those patients.

Healthy Returns: Diabetes drug Ozempic may lower dementia risk, nicotine use

Chicago, IL

Writers represent independent, third-party users who have joined our contributor program and self-verified their accounts. Writers are expected, like all users, to adhere to our Community Standards.

writer

Foodie in Chicago

Shortly before 3 AM, people in the Chicago area may have felt their houses shake as a 3.4-magnitude earthquake occurred about 60 miles west of the city. (CHICAGO) The United States Geological Survey (USGS) reported a 3.4-magnitude earthquake around Somonauk, IL. Somonauk is in DeKalb and LaSalle Counties, 64 miles west of Chicago.

Did You Feel the Earthquake?

Contributors represent independent, third-party users who have joined our contributor program and self-verified their accounts. They have also demonstrated their experience writing hard news for other outlets. Contributors are expected, like all users, to adhere to our Community Standards.

contributor

NewSantaAna

The FBI has seen a rise in scams targeting timeshare owners. In this kind of scam, criminals con these part-time property owners into shelling out hefty sums of cash, all under false pretenses related to their timeshare properties.

FBI warns that Mexican cartels are targeting Americans with timeshare scams

Review the multiple uses of metformin. A recent article on the multiple uses of metformin brings up the important topic of repurposing medications.1 Repurposing has been around since the advent of modern medicine. One prominent example is the use of chlorpromazine (CPZ) as an antipsychotic.2 Chlorpromazine was first synthesized in 1951 as a potentiator of general anesthesia.2 The psychiatric benefits were found later by Henri Laborit, a surgeon in the French army. He was doing research with artificial hibernation in prevention of surgical shock.2 Laborit employed the drug as an adjunct to anesthetics.2 He observed that CPZ at doses of 50 mg to 100 mg produced a lowering of body temperature, sedation, and disinterest without loss of consciousness.2 He was able to persuade his colleagues in the military hospital in Paris to try CPZ in the treatment of one of their patients who was experiencing psychotic agitation.2 Laborit hypothesized that since cooling with water had been used to treat agitation in France, the drug would have a similar effect.2 The mechanism of action was not fully known, and it was thought that it worked in controlling agitation because of its cooling effect and induction of “artificial hibernation” in patients.2 The pharmacological mechanism was not fully understood until many years later and the way it has impacted the practice of psychiatry needs no introduction. These “happy accidents” in medicine have played a vital role in getting where we are right now compared with just 50 years ago. This begs the question, are we onto another “happy accident” with metformin? There is an accumulating body of evidence that metformin may have benefits in aging that are beyond its effect on glycemic control.3.

Metformin, Inflammation, the Gut Microbiome, and Health Span: Connecting the Dots

California State

Alameda Post

California regulators just stopped AT&T from pulling the plug. California’s Public Utilities Commission on June 20 rejected AT&T’s application to stop providing landlines and other services in areas where there is no other option.

Still Need Your Landline?

The Healthy 

By 2050, 60% of US adults could be affected by heart disease and stroke, according to a June 2024 announcement from the American Heart Association (AHA). “The last decade has seen a surge of cardiovascular risk factors such as uncontrolled high blood pressure, diabetes and obesity, each of which raises the risks of developing heart disease and stroke,” Dhruv S. Kazi, MD, MS, associate director of the Richard A. and Susan F. Smith Center for Outcomes Research in Cardiology and director of the cardiac critical care unit at Beth Israel Deaconess Medical Center in Boston, says in the AHA’s press release. So how can we manage those risk factors?

New Research: If You’re Deficient in This Vitamin, It Could Raise Your Stroke Risk by 28%

(HealthDay News) — Glucose lowering by metformin is greater when given before enteral glucose among patients with type 2 diabetes controlled by metformin monotherapy, according to a study recently published in Diabetologia. Cong Xie, PhD, from the University of Adelaide in Australia, and colleagues studied 16 participants with type...

Timing of metformin important in metformin-treated type 2 diabetes

Irish Star

People with one key family member who were diagnosed with Alzheimer's at 65 or younger were also found to have higher-than-average amyloid levels in their brains, a new study has found

Alzheimer's risk is 'higher' if key member of your family has it

T3D reveals a significant relationship between brain dysfunction and glucose levels, a critical factor in AD. Insufficient glucose levels can lead to an aggressive decline in insight, judgment, memory, and reasoning. Limited research reveals a link between Alzheimer’s disease and type 2 diabetes. Additional research is needed to understand...

What Is Type 3 Diabetes?

Health

Reviewed by Ivy Kwong, LMFTReviewed by Ivy Kwong, LMFTIrritable bowel syndrome (IBS) and inflammatory bowel disease (IBD) are two chronic gastrointestinal disorders that share some overlapping symptoms, like abdominal pain, bloating, and diarrhea. While IBS and IBD have similar symptoms and acronyms, they are two distinct conditions with different underlying causes and treatment approaches. IBS is a functional disorder, meaning it affects how the intestines work but doesn't cause inflammation. IBD is an inflammatory disease that damages the gastrointestinal (GI) tract. In the United States, IBS affects between 25-45 million people, and IBD affects more than 3 million people.Symptoms of IBS vs....

What Is the Difference Between Irritable Bowel Syndrome (IBS) and Inflammatory Bowel Disease (IBD)?

Anika Jindal

Affluent people can splurge their money on the most luxurious possessions and lifestyles. However, most rich people are wise with money, refrain from making unnecessary purchases, and instead put their money to profitable use. Check out the list of 12 such things.

12 Things People Who Are Good With Money Will Never Spend On

Adults prescribed semaglutide were more likely to develop nonarteritic anterior ischemic optic neuropathy than those using non-GLP-1 medications. More studies are needed to determine causality. Adults with diabetes or obesity using semaglutide may have an increased risk for nonarteritic anterior ischemic optic neuropathy, a common form of optic neuropathy, according...

Adults prescribed semaglutide may have increased risk for form of optic neuropathy

Kentucky State

Northern Kentucky Tribune

Kentucky’s Community Actions Partnerships have announced the starts date for the Low-Income Home Energy Assistance Program (LIHEAP) Summer Subsidy, aimed at helping Kentucky households offset summer cooling costs.

LIHEAP Summer Subsidy program to help with summer cooling costs to begin enrollment July 16

New Jersey State

Morristown Minute

NEW JERSEY - Attorney General Matthew J. Platkin and the Division of Consumer Affairs announced today that Walmart has agreed to pay $1.64 million to settle allegations of unlawful unit pricing practices across its 64 New Jersey retail stores. The settlement, which includes a $1.61 million civil penalty, marks the largest ever obtained by the Division’s Office of Weights and Measures (OWM).

Walmart Pays $1.64M Settlement for Unlawful Pricing in NJ

New York Post

Lexapro, Paxil and Cymbalta carry a higher risk of packing on pounds than Zoloft, while Wellbutrin users are less likely to gain weight, according to a new study of eight popular antidepressants.

Harvard Pilgrim Health Care Institute (HPHCI) researchers analyzed the weights of more than 183,000 adult antidepressant users six months, a year and two years after they started taking the drugs.



Data from taking Celexa (citalopram), Lexapro (escitalopram), Prozac (fluoxetine), Paxil (paroxetine), Wellbutrin (bupropion), Cymbalta (duloxetine) and Effexor (venlafaxine) was compared to Zoloft (sertraline), which is the most prescribed antidepressant in the US.

At six months, Lexapro, Paxil and Cymbalta users were...

These popular antidepressants cause the most weight gain: Harvard research

Foralumab, an investigational nasal spray being developed by Tiziana Life Sciences, has been cleared by the U.S. Food and Drug Administration (FDA) for expanded use to treat moderate Alzheimer’s disease, and the first patient is expected to be dosed soon. An expanded use program, also called a compassionate use...

FDA clears foralumab nasal spray for expanded use in Alzheimer’s

NewsBreak

Novo Nordisk Gains as Ozempic Found To Lower Dementia Rates

American depositary receipts (ADRs) of Novo Nordisk rose in intraday trading Friday after an Oxford study showed the Danish company’s Ozempic diabetes drug was linked to...

Novo Nordisk Gains as Ozempic Found To Lower Dementia Rates

Comments / 0